Leaflet COLCHICINA IASIS 0.25mg / ml oral solution

Indicated for: gout; hyperuricemia

Route of administration: oral

Substance: colchicine (nonsteroidal anti-inflammatory drug)

ATC: M04AC01 (Musculo-skeletal system | Antigout preparations | Preparations with no effect on uric acid metabolism)

Precautions:
Avoid grapefruit
Avoid grapefruit

Avoid grapefruit and grapefruit juice.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Nephrotoxicity
Nephrotoxicity

This medicine may affect the kidneys.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Bleeding risk
Bleeding risk

This medicine may increase the risk of bleeding.

Ulcer / gastrointestinal bleeding
Ulcer / gastrointestinal bleeding

This medicine may increase the risk of ulcer or gastrointestinal bleeding.

Colchicine is a medication primarily used for the treatment and prevention of acute gout attacks and for managing familial Mediterranean fever. It works by reducing inflammation caused by the deposition of uric acid crystals in the joints, without affecting uric acid levels in the blood.

Colchicine is taken orally, and the dosage must be carefully adjusted to avoid toxicity. It is also used in other inflammatory conditions, such as recurrent pericarditis.

Side effects may include nausea, diarrhea, abdominal pain, or, in rare cases, severe toxicity manifested as bone marrow suppression, kidney failure, or muscle damage. It is contraindicated in patients with severe renal or hepatic impairment and should be used cautiously in those taking other medications that interact with colchicine.

General data about COLCHICINA IASIS 0.25mg / ml

  • Substance: colchicine
  • Date of latest medicines list: 01-02-2025
  • Product code: W70849001
  • Concentration: 0.25mg / ml
  • Pharmaceutical form: oral solution
  • Quantity: 1
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

  • Manufacturer: IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA
  • Holder: IASIS PHARMACEUTICALS HELLAS S.A. - GRECIA
  • Number: 15765/2025/01
  • Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-3 months

Pharmaceutical forms available for colchicine

Concentrations available for colchicine

  • 0.25mg/ml
  • 0.5mg
  • 1mg